NextUp: The Radnor-Based Biopharma Company Developing a Hormone-Targeting Treatment for Hypertension
Mineralys Therapeutics just completed a $40 million Series A funding round, which will allow them to take their lead drug candidate MLS-101 into a Phase II proof-of-concept study.
Here’s how Penn Medicine, Trinity Health, and community faith leaders collaborated on “operationalizing equity” around COVID-19 vaccine distribution.
Strella Biotechnology monitors an increase in ethylene production in fruit, signaling when produce needs to get to consumers before spoiling.
The FDA-cleared Lia pregnancy test is discreet, eco-friendly, and 99 percent accurate.
Precision medicine company Coriell Life Sciences is working to tailor treatment plans based on patients’ unique genetic makeups.
The Cancer Epigenetics Institute aims to increase therapy options for cancer patients and to promote educational opportunities for students and faculty.
The grant will allow for a more than 40,000-square-foot addition to their biopharmaceutical and biologics education and training center.
BioLattice is currently working on a prototype made from biologics and synthetic polymers.
The test is designed to work with existing RT-PCR instruments, meaning folks can now be screened for novel variants in addition to the original coronavirus.
Their findings reveal that Black, Latinx, and lower-income patients receive less early intervention for atrial fibrillation.
SOLUtion Medical’s TwistJect device allows people living with adrenal insufficiency to quickly and safely inject rescue medication in one step.
The Philly-based biotech company will begin human testing of EBT-101, a CRISPR-based gene editing construct developed at Temple’s Lewis Katz School of Medicine.
Here’s how Neuma works to ensure pharmaceutical and medtech companies are set up for success as they bring their products to market.
The program is working to improve the health and well-being of Montgomery County-based Black pregnant women, infants, and their families.
Project Onramp is seeking to bridge the opportunity gap for low-income and first-generation college students.